Dominique Paul Germain

19PUBLICATIONS
47CO-AUTHORS
Metabolic medicineGene and molecular therapyArtificial life and complex adaptive systemsMedical biochemistry - amino acids and metabolitesEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 10, 2026
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension.

Peter Nordbeck, Ozlem Goker-Alpan, John A Bernat

|Nov 17, 2025
Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease.

Dominique P Germain, Pronabesh DasMahapatra, Shiguang Liu

|Apr 17, 2025
Applying artificial intelligence to rare diseases: a literature review highlighting lessons from Fabry disease.

Dominique P Germain, David Gruson, Marie Malcles

|Nov 27, 2024
Safety and Tolerability of a Shorter Agalsidase Beta Infusion Time in Patients with Classic or Later-Onset Fabry Disease.

Dominique P Germain, Alice Porto Vasconcelos, Lien Tran Thi Phuong

|Sep 28, 2024
Prevalence of Fabry Disease in Patients on Dialysis in France.

Florence Sens, Laure Guittard, Bertrand Knebelmann

|Dec 04, 2023
Impact of <i>GLA</i> Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies.

Emanuele Monda, Gaetano Diana, Francesca Graziani

Pageof 4

Frequent Collaborators

3 joint publications

Derralynn Hughes

2 joint publications

Alessandro P Burlina

1 joint publications

R Manara

1 joint publications

R Y Carlier